Delivery Order SPE2DB22D2009-SPE2DB23FM4GW
Award Date 9/20/23
Potential Completion Date 9/21/23
Potential Value $202
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $373,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 100 units of 2.5 mg methotrexate tablets. As one of the largest pharmaceutical distributors supporting the Department of Defense supply chain, Amerisourcebergen will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania by July 20, 2023 to fulfill DLA requirements. The delivery order was issued under an existing DLA-wide supply...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $739 to Amerisourcebergen Drug Corporation for the supply of 100 tablets of 2.5 mg methotrexate. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The period of performance is September 21-22, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for a common drug supports the Agency's mission to provide critical...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $199.65 to Amerisourcebergen Drug Corp for the supply of 100 units of 2.5 mg Methotrexate tablets. As the prime contractor, Amerisourcebergen Drug Corp will deliver the pharmaceutical products from its facility located in Conshohocken, Pennsylvania under a one-day period of performance beginning August 1, 2023. The Defense Logistics Agency routinely utilizes indefinite delivery/indefinite quantity contracts to...
- The Defense Logistics Agency awarded a $1,026.06 firm fixed price delivery order to Amerisourcebergen Drug Corp for 100 tablets of 2.5 mg methotrexate. The prime contractor, a division of Amerisourcebergen Corporation, will deliver the pharmaceutical products to a facility in Conshohocken, Pennsylvania within the period of performance from August 22 to August 23, 2023. The Defense Logistics Agency utilizes contracts such as this to efficiently procure medical supplies in support of the...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $37,470 to Amerisourcebergen Drug Corporation to supply 20 tablets of 2.5 mg methotrexate. Performance will take place in Conshohocken, Pennsylvania under the prime contractor's corporate office division. No additional details were provided on the original solicitation or any overarching contract vehicles. Amerisourcebergen Corporation, the parent company of the prime, will perform the order through its...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $306.02 to Amerisourcebergen Drug Corp for the supply of 100 tablets of 2.5 mg methotrexate. Amerisourcebergen Drug Corp will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania under the terms of the order, which runs from September 6 to September 7, 2023. As a major provider of medical supplies and logistics support to the U.S. Department of Defense, the Defense Logistics Agency...
- The Defense Logistics Agency awarded a delivery order valued at approximately $1,098 to Amerisourcebergen Drug Corporation for the supply of 100 units of 2.5 mg methotrexate tablets. The order was placed under an existing prime vendor contract held by Amerisourcebergen with DLA to provide pharmaceutical products and services in support of DOD missions. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of four days from July 21 through July 24,...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at sixty-six thousand one hundred ten dollars to Amerisourcebergen Drug Corporation for one hundred tablets of two and a half milligram methotrexate. The prime contractor, a division of Amerisourcebergen Corporation, will fulfill the order from its facility in Conshohocken, Pennsylvania by September first, twenty twenty-three. No major subcontractors or set aside designations were indicated. The Defense Logistics...
- The Defense Logistics Agency awarded a delivery order under an indefinite-delivery/indefinite-quantity contract vehicle to Amerisourcebergen Drug Corporation for the supply of 100 units of 2.5 mg methotrexate tablets at a value of $573.57. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one-day period concluding on July 27, 2023. The firm fixed price contract has no set-aside designation and supports the DLA's medical supply procurement programs. As...
- The Defense Logistics Agency awarded a $89,520 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 100 units of 2.5 mg methotrexate tablets. As one of the largest medical-surgical prime vendors supporting the Department of Defense worldwide healthcare system, Amerisourcebergen will deliver the pharmaceutical products to a facility in Conshohocken, Pennsylvania by July 7, 2023 to fulfill DLA requirements. No subcontractors or set aside designations were...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB23FM4GWDelivery Order
The Defense Logistics Agency awarded a $201,720 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 100 units of 2.5 mg methotrexate tablets. As a major pharmaceutical distributor, Amerisourcebergen will deliver the generic tablets to a facility in Conshohocken, Pennsylvania in support of the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were specified. The single day period of performance from September 20 through 21, 2023 indicates an expedited delivery requirement for this pharmaceutical product.
Generated 12/20/23, 9:20 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $202 | 9/20/23 |